Novartis Urges International Pressure On India To Adhere To IP Rules
This article was originally published in PharmAsia News
Executive Summary
Switzerland's Novartis, a big player among Europe's pharmaceutical elites, has been calling for international pressure on India to respect intellectual property rights for drugs.